Abstract:An X-ray absorption spectroscopy (XAS) electrochemical cell was used to collect high-quality XAS measurements of N-truncated Cu:amyloid-β (Cu:Aβ) samples under near-physiological conditions. N-truncated Cu:Aβ peptide complexes contribute to oxidative stress and neurotoxicity in Alzheimer's patients' brains. However, the redox properties of copper in different Aβ peptide sequences are inconsistent. Therefore, the geometry of binding sites for the copper binding in Aβ4–8/12/16 was determined using novel advanced extended X-ray absorption fine structure (EXAFS) analysis. This enables these peptides to perform redox cycles in a manner that might produce toxicity in human brains. Fluorescence XAS measurements were corrected for systematic errors including defective-pixel data, monochromator glitches and dispersion of pixel spectra. Experimental uncertainties at each data point were measured explicitly from the point-wise variance of corrected pixel measurements. The copper-binding environments of Aβ4–8/12/16 were precisely determined by fitting XAS measurements with propagated experimental uncertainties, advanced analysis and hypothesis testing, providing a mechanism to pursue many similarly complex questions in bioscience. The low-temperature XAS measurements here determine that CuII is bound to the first amino acids in the high-affinity amino-terminal copper and nickel (ATCUN) binding motif with an oxygen in a tetragonal pyramid geometry in the Aβ4–8/12/16 peptides. Room-temperature XAS electrochemical-cell measurements observe metal reduction in the Aβ4–16 peptide. Robust investigations of XAS provide structural details of CuII binding with a very different bis-His motif and a water oxygen in a quasi-tetrahedral geometry. Oxidized XAS measurements of Aβ4–12/16 imply that both CuII and CuIII are accommodated in an ATCUN-like binding site. Hypotheses for these CuI, CuII and CuIII geometries were proven and disproven using the novel data and statistical analysis including F tests. Structural parameters were determined with an accuracy some tenfold better than literature claims of past work. A new protocol was also developed using EXAFS data analysis for monitoring radiation damage. This gives a template for advanced analysis of complex biosystems.

Key Roles of Tyr 10 in Cu Bound Aβ Complexes and Its Relevance to Alzheimer's Disease

Redox behaviour of Cu-Aβ(4-16) complexes related to Alzheimer's Disease

Dual Functions of Beta-Amyloid Oligomer and Fibril in Cu(Ii)-Induced H2o2 Production

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro

Heme-Aβ in SDS micellar environment: Active site environment and reactivity

Redox-active metals, oxidative stress, and Alzheimer's disease pathology.

Copper catalyzed oxidation of alzheimer A beta

Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.

Metalloenzyme-like Activity of Alzheimer's Disease Β-Amyloid

The mechanism for heme to prevent Aβ 1–40 aggregation and its cytotoxicity

Redox Reactions Of The Alpha-Synuclein-Cu2+ Complex And Their Effects On Neuronal Cell Viability

Nanostructure and dynamics of N-truncated copper amyloid-β peptides from advanced X-ray absorption fine structure

Characterization of Copper Binding to the Peptide Amyloid-Beta(1-16) Associated with Alzheimer'S Disease

Hydrogen Peroxide Can Be Generated by Tau in the Presence of Cu(II)

Altered Copper Transport in Oxidative Stress-Dependent Brain Endothelial Barrier Dysfunction Associated with Alzheimer′s Disease

Truncated and Modified Aβ Species in Alzheimer's Disease